Combination of plasma CP, anti-CCP antibody and Hyp gave specific and sensitive detection and discrimination of eOA, eRA, non-RA and good skeletal health, exploiting the discovery of CP in eOA, low levels in healthy people and differential autoimmunity of CP in eOA and eRA. This evidence concerns the gene CP and rheumatoid arthritis.